[Severe hypoglycemic reactions during peroral treatment of diabetes with N1-sulfanilyl-n-2-n-butylcarbamid (BZ 55)].
D003920:Diabetes Mellitus / Q000628:therapy*; D007003:Hypoglycemia / Q000209:etiology*; D007004:Hypoglycemic Agents; D000077145:Sulfanilamide; D013424:Sulfanilamides / Q000031:analogs & derivatives; D014508:Urea / Q000031:analogs & derivatives
D007004:Hypoglycemic Agents; D013424:Sulfanilamides; D000077145:Sulfanilamide; D014508:Urea
DIABETES MELLITUS/therapy; HYPOGLYCEMIA/etiology and pathogenesis; SULFANILAMIDE/related compounds; UREA/related compounds
Schwere hypoglykämische Reaktionen im Verlauf der peroralen Diabetesbehandlung mit N1-sulfanilyl-N2-n-butylcarbamid (BZ 55).